معرفی
Danielle Kamato serves as an Honorary Senior Fellow/Lecturer at the School of Pharmacy and Pharmaceutical Sciences, University of Queensland. Her primary affiliation centers on vascular pharmacology research within this institution.
Her research focuses on molecular mechanisms underlying atherosclerosis, particularly G-protein coupled receptor (GPCR) transactivation of kinase receptors, Smad linker region phosphorylation, and glycosaminoglycan synthesis in vascular smooth muscle cells. Key areas include TGF-β signaling pathways, endothelin-1 mediated vascular remodeling, and lipoprotein retention mechanisms in arterial walls. Recent work explores connections between inflammatory bowel disease and cardiovascular complications, natural product interventions like moscatilin for vascular calcification, and drug repurposing strategies.
Analysis of her publication record reveals consistent emphasis on vascular signaling pathways with strong translational focus. The 15 most recent articles demonstrate expertise in GPCR-TGFβ crosstalk (12/15), vascular calcification mechanisms (3/15), and nanoparticle drug delivery (2/15), spanning cardiovascular pharmacology, molecular signaling, and translational therapeutics.
- No scientific awards or major fellowships were documented in the source material
Dr. Kamato's collaborative research network includes prominent figures like Peter J. Little, Suowen Xu, and Narin Osman, with extensive work on kinase receptor transactivation mechanisms. Her publications indicate significant contributions to understanding Smad phosphorylation pathways and GPCR-mediated vascular disease processes, though specific grant details remain unreported in the source text.
Her laboratory work appears centered on vascular smooth muscle cell signaling, with investigations into proteoglycan synthesis, receptor transactivation, and therapeutic interventions targeting atherosclerosis progression.
